Characteristics for Medical Cannabis Treatment Adherence Among Autistic Children and Their Families: A Mixed-Methods Analysis

Q1 Medicine
Ayelet David, O. Stolar, M. Berkovitch, E. Kohn, Michal Waisman-Nitzan, Inbar Hartmann, Eynat Gal
{"title":"Characteristics for Medical Cannabis Treatment Adherence Among Autistic Children and Their Families: A Mixed-Methods Analysis","authors":"Ayelet David, O. Stolar, M. Berkovitch, E. Kohn, Michal Waisman-Nitzan, Inbar Hartmann, Eynat Gal","doi":"10.1159/000538901","DOIUrl":null,"url":null,"abstract":"IIntroduction. Medical cannabis treatment for autistic children has recently become popular, and studies have focused on examining the treatment’s effects on children’s symptom presentation, reported side effects, and dropout rates. However, no previous study has investigated the factors influencing adherence and dropout rates in cannabis treatment. Method. This explanatory sequential mixed-methods study explored these factors by examining the characteristics of 87 autistic children and their families and deepening parents’ perspectives and experiences of the 6-month CBD-rich cannabis treatment’s benefits and barriers. Results. We found this treatment to have a high (75%) adherence rate, relatively mild side effects, and substantial reported benefits for the children and families. However, this treatment was not free of barriers; the intake regime, some side effects, and in some cases, unrealistic parental expectations made adherence difficult for some families. Conclusion. Our results highlight the importance of providing professional guidance and knowledge to parents of autistic children, enhancing their understanding of the impact of CBD-rich cannabis treatment on their children and expected related challenges and coordinating realistic treatment expectations. We hope that addressing these important aspects will influence parents’ ability to adhere to and enjoy the benefits of cannabis treatment for their autistic children.","PeriodicalId":18415,"journal":{"name":"Medical Cannabis and Cannabinoids","volume":"100 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Cannabis and Cannabinoids","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000538901","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

IIntroduction. Medical cannabis treatment for autistic children has recently become popular, and studies have focused on examining the treatment’s effects on children’s symptom presentation, reported side effects, and dropout rates. However, no previous study has investigated the factors influencing adherence and dropout rates in cannabis treatment. Method. This explanatory sequential mixed-methods study explored these factors by examining the characteristics of 87 autistic children and their families and deepening parents’ perspectives and experiences of the 6-month CBD-rich cannabis treatment’s benefits and barriers. Results. We found this treatment to have a high (75%) adherence rate, relatively mild side effects, and substantial reported benefits for the children and families. However, this treatment was not free of barriers; the intake regime, some side effects, and in some cases, unrealistic parental expectations made adherence difficult for some families. Conclusion. Our results highlight the importance of providing professional guidance and knowledge to parents of autistic children, enhancing their understanding of the impact of CBD-rich cannabis treatment on their children and expected related challenges and coordinating realistic treatment expectations. We hope that addressing these important aspects will influence parents’ ability to adhere to and enjoy the benefits of cannabis treatment for their autistic children.
自闭症儿童及其家庭坚持医用大麻治疗的特征:混合方法分析
导言。针对自闭症儿童的医用大麻治疗近来很受欢迎,相关研究主要集中在研究这种治疗对儿童症状表现、报告的副作用和辍学率的影响。然而,此前还没有研究调查过影响大麻治疗依从性和辍学率的因素。研究方法。这项解释性顺序混合方法研究通过考察 87 名自闭症儿童及其家庭的特征来探索这些因素,并加深家长对 6 个月富含 CBD 的大麻治疗的益处和障碍的看法和体验。结果。我们发现这种治疗方法的坚持率很高(75%),副作用相对较小,而且儿童和家庭都表示受益匪浅。但是,这种治疗方法也并非没有障碍;摄入制度、一些副作用以及在某些情况下家长不切实际的期望都使一些家庭难以坚持治疗。结论我们的研究结果凸显了为自闭症儿童家长提供专业指导和知识的重要性,加深了他们对富含 CBD 的大麻治疗对其子女的影响和预期相关挑战的理解,并协调了现实的治疗期望。我们希望,解决这些重要方面的问题将影响家长坚持治疗自闭症儿童并从中获益的能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical Cannabis and Cannabinoids
Medical Cannabis and Cannabinoids Medicine-Complementary and Alternative Medicine
CiteScore
6.00
自引率
0.00%
发文量
18
审稿时长
18 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信